Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v9-EN Version v4-EN
Language English English
Date Updated 2018-02-23 2018-02-12
Drug Identification Number 00868965 00868965
Brand name SUPRAX SUPRAX
Common or Proper name Cefixime for oral suspension Cefixime for oral suspension
Company Name ODAN LABORATORIES LTD ODAN LABORATORIES LTD
Ingredients CEFIXIME CEFIXIME
Strength(s) 100MG 100MG
Dosage form(s) POWDER FOR SUSPENSION POWDER FOR SUSPENSION
Route of administration ORAL ORAL
Packaging size 50 mL 50 mL
ATC code J01DD J01DD
ATC description OTHER BETA-LACTAM ANTIBACTERIALS OTHER BETA-LACTAM ANTIBACTERIALS
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date 2018-02-07 2018-02-07
Actual start date 2018-02-07 2018-02-07
Estimated end date 2018-02-21 2018-02-21
Actual end date 2018-02-22
Shortage status Resolved Actual shortage
Company comments
Health Canada comments